Description
BSE announces the upcoming listing and admission to dealings of equity shares of Gujarat Kidney and Super Speciality Limited with scrip code 544666 and symbol GKSL.
Summary
BSE has informed trading members that equity shares of Gujarat Kidney and Super Speciality Limited will be listed and admitted to dealings on the exchange in due course. The company has been assigned scrip code 544666, symbol GKSL, and ISIN number INE0V0W01025. The exact date of listing and complete details of the securities will be communicated through a separate notice.
Key Points
- Gujarat Kidney and Super Speciality Limited equity shares approved for BSE listing
- Scrip Code: 544666
- Symbol: GKSL
- ISIN: INE0V0W01025
- Listing date to be announced separately
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE Limited
Regulatory Changes
No regulatory changes. This is a standard listing notification.
Compliance Requirements
Trading members should note the company details for future trading once the listing date is announced:
- Company Name: Gujarat Kidney and Super Speciality Limited
- Scrip Code: 544666
- Trading Symbol: GKSL
- ISIN: INE0V0W01025
Important Dates
- Notice Date: December 29, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine listing announcement with minimal immediate market impact. Trading members are informed to prepare for trading in GKSL once the specific listing date is announced. The company operates in the healthcare/specialty hospital sector. Investors interested in this sector should await the separate notice containing the listing date and complete security details before trading commences.
Impact Justification
Routine listing announcement for a single company. Specific listing date to be announced separately. Limited immediate market impact.